Characterization and In vitro Release & In vivo Behavior Study of Self-Assembled Nano-Emulsion in XiaoYao Pill for Enhanced Drug Delivery

生物利用度 药代动力学 体内 化学 药理学 阿魏酸 色谱法 药物输送 医学 生物 有机化学 生物技术
作者
Z Yuan,Qingxia Guan,Zhu Meiwei,Wang LianZhi,Fangfang Yang,Zhiping Yang,Zhongxin Chen,Dai Xiaofang
出处
期刊:Current Drug Delivery [Bentham Science Publishers]
卷期号:22
标识
DOI:10.2174/0115672018303538240827102421
摘要

Background: Traditional Chinese medicine formulations often contain hydrophobic components with limited solubility and stability, leading to low oral bioavailability. Self-assembled nanoparticles (SANs) have shown promise in enhancing oral bioavailability of these components. However, whether un-decocted Chinese herbal pellets can generate SANs and the impact of SANs formed by multiple components on pharmacokinetic parameters remains unexplored. Methods: In this study, single-factor approach was employed to determine the optimal separation method of nano-emulsion phase of XiaoYao pill (N-XY). Morphological and particle size analyses confirmed the nanoscale nature of N-XY. High-performance liquid chromatography (HPLC) fingerprint analysis was conducted to compare the distribution of active ingredients among three different phases of XiaoYao pill (XY pill). In vitro release studies were performed to evaluate the release mechanism of four ingredients from N-XY. Additionally, in vivo pharmacokinetics and tissue distribution behaviors were investigated in rats. Results: N-XY exhibited uniform and stable characteristics as a water-in-oil (O/W) nano-emulsion. Fingerprint analysis identified 25 characteristic peaks and 8 key ingredients in N-XY, with the highest peak areas. In vitro release studies showed a sustained release behavior of N-XY. The pharmacokinetics study showed that the ferulic acid of N-XY had a 1.37-fold higher AUC, 1.44-fold lower Vd/F, 1.39-fold lower CL/F, and a prolonged t1/2 than A-XY, indicating enhanced bioavailability due to reduced elimination. Furthermore, the tissue distribution revealed that the levels of paeoniflorin and ferulic acid from N-XY significantly increased in liver, spleen, lungs, uterus and ovaries, exhibiting targeting characteristics. Conclusion: This study comprehensively explored the formation, characterization, and pharmacokinetics of nano-emulsion in XY pill, introducing novel perspectives and initiating preliminary research on potential SANs in un-decocted traditional Chinese medicine formulations. It also emphasized the importance of enhancing pharmacokinetics of hydrophobic components in Chinese herbal formulations and laid the foundation for future nano-formulation research for XY pill.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
抗体药物偶联完成签到,获得积分10
6秒前
6秒前
科研通AI5应助程雯慧采纳,获得10
6秒前
快乐的芷巧完成签到,获得积分20
6秒前
桐桐应助lily采纳,获得20
9秒前
9秒前
Lyn完成签到 ,获得积分10
9秒前
义气乐儿完成签到,获得积分10
9秒前
10秒前
奋斗含巧发布了新的文献求助10
11秒前
orixero应助jinzheng采纳,获得10
12秒前
lizhiqian2024发布了新的文献求助10
15秒前
义气乐儿发布了新的文献求助10
16秒前
zhzzhz完成签到,获得积分10
16秒前
蟲先生完成签到 ,获得积分0
16秒前
依梦完成签到,获得积分10
16秒前
小蘑菇应助ayzl采纳,获得10
17秒前
靖哥哥完成签到,获得积分10
18秒前
大模型应助zm采纳,获得10
22秒前
ZHANG123完成签到,获得积分10
22秒前
SS发布了新的文献求助10
24秒前
醉熏的天薇完成签到,获得积分10
24秒前
25秒前
25秒前
25秒前
27秒前
SciGPT应助阿辉采纳,获得10
29秒前
29秒前
科研通AI5应助nini采纳,获得10
30秒前
sjxbjrndkd发布了新的文献求助10
30秒前
百宝给百宝的求助进行了留言
30秒前
lily发布了新的文献求助20
30秒前
斯寜应助科研通管家采纳,获得10
32秒前
乐乐应助科研通管家采纳,获得10
32秒前
32秒前
乐乐应助科研通管家采纳,获得10
32秒前
子凡应助科研通管家采纳,获得10
32秒前
爆米花应助科研通管家采纳,获得10
32秒前
斯寜应助科研通管家采纳,获得10
32秒前
32秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Technologies supporting mass customization of apparel: A pilot project 450
Mixing the elements of mass customisation 360
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
Political Ideologies Their Origins and Impact 13th Edition 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3781766
求助须知:如何正确求助?哪些是违规求助? 3327359
关于积分的说明 10230631
捐赠科研通 3042226
什么是DOI,文献DOI怎么找? 1669897
邀请新用户注册赠送积分活动 799391
科研通“疑难数据库(出版商)”最低求助积分说明 758792